Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0213 | uM | 12365.167 | 0.9850 | 0.9851 | 2.0273 | |
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12365.167 | 1.0405 | 1.0395 | 2.0273 | |
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12365.167 | 0.9957 | 0.9957 | 2.0273 | |
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12365.167 | 0.9934 | 0.9934 | 2.0273 | |
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12365.167 | 1.1002 | 1.0964 | 2.0273 | |
MCF12A | NM | Basal B | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12365.167 | 1.0839 | 1.0811 | 2.0273 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10997.154 | 0.9510 | 0.9106 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10997.154 | 1.0095 | 1.0173 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10997.154 | 0.9778 | 0.9596 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10997.154 | 0.9320 | 0.8757 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10997.154 | 1.0068 | 1.0123 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10997.154 | 0.9560 | 0.9197 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10997.154 | 0.9905 | 0.9827 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10997.154 | 0.9785 | 0.9609 | 1.0978 | |
MCF7 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10997.154 | 0.9904 | 0.9825 | 1.0978 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10519.142 | 0.9114 | 0.8032 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10519.142 | 0.9521 | 0.8935 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10519.142 | 0.9308 | 0.8463 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10519.142 | 0.9316 | 0.8480 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10519.142 | 0.9396 | 0.8657 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10519.142 | 0.9475 | 0.8832 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10519.142 | 0.9617 | 0.9148 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10519.142 | 0.9093 | 0.7987 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10519.142 | 0.8516 | 0.6717 | 0.8963 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10998.154 | 0.9001 | 0.7351 | 0.7412 |